The two companies headline Big Tech earnings during a week in which more than 100 S&P 500 companies report. Economic data ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter ...

A challenging economic environment is constricting biotech deal flow. But for well-capitalized Lantheus, these tough times ...

AZN's key medicines, mainly cancer drugs, Lynparza, Tagrisso and Imfinzi, are expected to have driven the company's top line.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...